ARMP (Armata Pharmaceuticals) Future Price to Earnings

Corporate company logo of Armata (ARMP)

Armata Pharmaceuticals (ARMP) specializes in developing microorganism-based biologics to combat infections. By optimizing costs, the company utilizes external laboratories for testing while retaining full intellectual property rights to its developments. This daily price action reflects a Forward P/E of 0.00. Growth prospects are based on support from Innoviva and the development of phage-based therapies for cystic fibrosis amid a shortage of effective antibiotics.

ARMP - armatapharma.com Market Cap to Projected Earnings over the range 07/04/2022 - 11/14/2026

Financial and market metric breakdowns for Armata (ARMP)

- current price and projected stock value:
Stock Quotes Armata Pharmaceuticals, Inc.|ARMP - Fair Value Consensus
- business market valuation indicators:
Market Value Armata Pharmaceuticals Inc|ARMP - Real Price to Acquire Entire Company
- balance sheet equity data:
Book Value per Share Armata Pharmaceuticals|ARMP - Book Valuation of Business|Market Capitalization to Book Value Ratio armatapharma.com|ARMP - Cumulative Company Assets
- issuer credit burden and liquidity indicators:
Debt to Equity Armata Pharmaceuticals|ARMP - Long-Term Debt to Capital Coefficient|Short-Term Debt to Equity Armata Pharmaceuticals|ARMP - Company Cumulative Debt|Debts to Book Capitalization Armata Pharmaceuticals Inc|ARMP - Company Long-Term Debt|Company Short-Term Debts Armata Pharmaceuticals|Quick Liquidity armatapharma.com
- earnings and market ratios statistics:
ARMP - Net Financial Result|Projected Future Earnings Armata Pharmaceuticals|ARMP - P/E Multiple|Future Price to Earnings Armata Pharma|ARMP - Growth-Adjusted Payback Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Armata Pharmaceuticals Inc|ARMP - Operating profit before deduction of amortization|Net earnings per share (EPS TTM) Armata Pharmaceuticals|ARMP - Net earnings per share (EPS TTM)|Year-over-year net earnings per share growth for the last 12 months armatapharma.com|ARMP - Net earnings per one share growth for the current year|Earnings growth forecast for next year Armata Pharmaceuticals
- revenue and sales proceeds data:
ARMP - Revenue and Sales Volume|Company Future Sales Volume Armata Pharmaceuticals, Inc.|ARMP - Market Capitalization-to-Revenue Ratio|Price-to-Projected Revenue Ratio Armata Pharmaceuticals Inc
Analysis of all company metrics:Armata Pharmaceuticals, Inc.
Signature product of Armata Pharmaceuticals

Forward P/E determines market expectations for the investment payback period based on projected net income. This metric serves as a portfolio stress-testing tool, identifying the risk of asset overvaluation or undervaluation. By analyzing the forward P/E dynamics of a company, an investor assesses the stability of its capitalization. For Armata Pharmaceuticals (ARMP), this indicator reflects market confidence in the monetization of bioscreening automation. The implementation of AI software in preclinical stages must justify current multiples.

Competing companies

Projected Price to Earnings ACXP (Acurx Pharmaceuticals)